NON-INVASIVE CANCER DIAGNOSTICS MARKET ANALYSIS

Regional Analysis

Non-Invasive Cancer Diagnostics Market - Regional Analysis

On the basis of region, the global non-invasive cancer diagnostics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the non-invasive diagnostics market, owing to increasing incidence of cancer, increasing technological advancement, better reimbursement scenario, and governmental initiatives for screening of cancer in early stages. For instance, the American Cancer Society Guidelines for the early detection of cancer offers various screening plans at different ages. For example, the guidelines suggest that women between the age of 40 and 44 must screen for breast cancer annually. Moreover market players in the APAC region are involved in partnerships and agreements to enhance the market growth in cancer diagnostics. For instance, In April 2019, Halifax signed an exclusive distribution agreement with Genecast to make Immunoscore assay available in China.